CYTK

Cytokinetics Inc (CYTK)

US
$ 313.8%

Price Chart

Key Statistics

Market Cap
$ 3.56B
P/E Ratio
0.00
Revenue (TTM)
$ 19.22M
Volume
1.99M
52W High
$ 61.40
52W Low
$ 29.31
Dividend Yield
0.00%
Beta
0.81

Technicals

50-Day MA
39.5204
200-Day MA
48.5284
52 Week High
61.4
52 Week Low
29.31

About CYTK

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating di.

Employees
498
Headquarters
South San Francisco, CA
CEO
Mr. Robert I. Blum

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg